Stock-Based Compensation

6 Months Ended

Jun. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

The Company classifies stock-based compensation expense in the accompanying Condensed Consolidated Statements of Operations and Comprehensive Loss, based on the department to which the recipient belongs. Stock-based compensation expense included in cost of goods sold and operating expenses during the three and six months ended June 30, 2016 and 2015, was as follows:



	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2016		2015		2016		2015
Cost of goods sold	$	259	$	226	$	532	$	474
Operating expenses:
Research and development	434		258		797		486
Clinical and regulatory affairs	593		243		493		428
Marketing and sales	1,261		839		2,391		1,587
General and administrative	1,339		842		2,555		1,644
Total operating expenses	$	3,627	$	2,182	$	6,236	$	4,145
Total	$	3,886	$	2,408	$	6,768	$	4,619

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details